SCHEMBL14518959

SCHEMBL14518959

CCCNCN1CCC(C(C(C)=O)(c2ccccc2)c2ccccc2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 4/20 0.42
▸ CYP2J2 P51589 3/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2B6 P20813 1/20 0.40
▸ CHRM1 P11229 2/20 0.40
▸ DRD2 P14416 2/20 0.40
▸ ADRA2B P18089 2/20 0.40
▸ ADRA2C P18825 2/20 0.40
▸ CHRM3 P20309 2/20 0.40
▸ ADRA1A P35348 2/20 0.40
▸ OPRK1 P41145 2/20 0.40
▸ KCNH2 Q12809 2/20 0.40
▸ GHSR Q92847 2/20 0.40
▸ SIGMAR1 Q99720 2/20 0.40
▸ ADRB2 P07550 1/20 0.40
▸ CHRM2 P08172 1/20 0.40
▸ CHRM4 P08173 1/20 0.40
▸ ADRB1 P08588 1/20 0.40
▸ CHRM5 P08912 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13785557 0.84 DRD2 (0.47) OPRM1CYP2J2CYP3A4CYP2C9CYP2B6
SCHEMBL13601296 0.84 OPRM1 (0.44) OPRM1CYP2J2CYP3A4CYP2C9CYP2B6
SCHEMBL13785556 0.82 CYP2J2 (0.51) OPRM1CYP2J2CYP3A4CYP2C9CYP2B6
SCHEMBL14518960 0.81 KCNH2 (0.44) OPRM1CYP2J2CHRM1DRD2ADRA2B
SCHEMBL13601289 0.81 OPRM1 (0.42) OPRM1CYP2J2CHRM1DRD2ADRA2B
SCHEMBL13785561 0.77 CYP2J2 (0.49) OPRM1CYP2J2CYP3A4CYP2C9CYP2B6
SCHEMBL12052721 0.77 KCNH2 (0.44) OPRM1CYP2J2CYP3A4CYP2C9CYP2B6
SCHEMBL5099271 0.76 CHRM3 (0.57) OPRM1CYP2J2CYP3A4CYP2C9CYP2B6
SCHEMBL5095693 0.76 CHRM3 (0.57) OPRM1CYP2J2CYP3A4CYP2C9CYP2B6
SCHEMBL5109615 0.76 CHRM3 (0.57) OPRM1CYP2J2CYP3A4CYP2C9CYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7208515-B2 Diphenylmethyl compounds useful as muscarinic receptor antagonists THERAVANCE, INC. (US) 2007-04-24 — — US disclosed
Send feedback